Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Candesartan Cilexetilx

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Candesartan Cilexetil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 722Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Prinston's Generic Candesartan Cilexetil Receives Approval in the U.S.
    Prinston's Generic Candesartan Cilexetil Receives Approval in the U.S.

    24 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206233

    FDA
    24 Aug 2023
    Share Share
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs

    27 Nov 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html

    BUSINESS-STANDARD
    27 Nov 2022
    Share Share
    Enforcement Report - Week of September 22, 2021
    Enforcement Report - Week of September 22, 2021

    22 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf

    FDA
    22 Sep 2021
    Share Share
    China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests
    China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests

    05 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/china-pharmas-candesartan-hypertension-product-passes-bioequivalence-tests-and-the-company-plans-to-apply-for-nmpa-approval-301348981.html

    PRNEWSWIRE
    05 Aug 2021
    Share Share
    Candesartan Is Associated With Lower Amyloid Accumulation
    Candesartan Is Associated With Lower Amyloid Accumulation

    26 Jul 2021

    // FIRSTWORDPHARMA

    https://www.firstwordpharma.com/node/1849161?tsid=4

    FIRSTWORDPHARMA
    26 Jul 2021
    Share Share
    Candesartan Is Associated With Lower Amyloid Accumulation
    Candesartan Is Associated With Lower Amyloid Accumulation

    26 Jul 2021

    // FIRSTWORDPHARMA

    https://www.firstwordpharma.com/node/1849161?tsid=4

    FIRSTWORDPHARMA
    26 Jul 2021
    Share Share